½ÃÀ庸°í¼
»óÇ°ÄÚµå
1526808
¼¼°èÀÇ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå : À¯Çüº°, µðÀÚÀκ°, ¼ÒÀ纰, ¿ëµµº°, Áö¿ªº° - ¿¹Ãø(-2030³â)Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030 |
ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 10.8%ÀÇ CAGR·Î È®´ëµÇ¾î 2024³â 71¾ï ´Þ·¯¿¡¼ 2030³â 131¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀº ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿°, ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÌ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â Áï½Ã »ç¿ë °¡´ÉÇÑ ¿ë·®À» Á¦°øÇÔÀ¸·Î½á ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ°í Åõ¾à ¿À·ù °¡´É¼ºÀ» ³·Ãç ¸¸¼ºÁúȯ ȯÀÚ¿¡°Ô Á¤È®ÇÏ°í ÀÏ°üµÈ ¾à¹° Åõ¿©¸¦ ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÚ°¡ Åõ¾àÀÇ Áõ°¡ Ãß¼¼µµ ½ÃÀå ¼ºÀå¿¡ Å« ¿ªÇÒÀ» ÇÏ°í ÀÖ½À´Ï´Ù. ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â ¿ë·® ÃøÁ¤ÀÌ ÇÊ¿ä ¾ø¾î ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í, ¿À¿° À§ÇèÀÌ ³·À¸¸ç, Æí¾ÈÇÔ°ú »ç¿ë ÆíÀǼºÀ¸·Î ÀÎÇØ È¯Àڵ鿡°Ô ¼±È£µÇ°í ÀÖ½À´Ï´Ù.
Á¶»ç ¹üÀ§ | |
---|---|
Á¶»ç ´ë»ó ¿¬µµ | 2022-2030³â |
±âÁØ ¿¬µµ | 2023³â |
¿¹Ãø ±â°£ | 2024-2030³â |
°ËÅä ´ÜÀ§ | ±Ý¾×(10¾ï ´Þ·¯) |
ºÎ¹®º° | À¯Çüº°, µðÀÚÀκ°, ¼ÒÀ纰, ¿ëµµº°, Áö¿ªº° |
´ë»ó Áö¿ª | ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, GCC ±¹°¡ |
À¯Çüº°·Î´Â ¸î °¡Áö ¿äÀÎÀ¸·Î ÀÎÇØ ±âÁ¸ ÇÁ¸®ÇÊµå ½Ã¸°Áö ºÎ¹®ÀÌ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÁ¸®ÇÊµå ½Ã¸°Áö´Â Áï½Ã »ç¿ë °¡´ÉÇÑ Æ¯¼º°ú ¹Ì¸® °è·®µÈ ¿ë·®À¸·Î ÀÎÇØ Áغñ ½Ã°£°ú Åõ¾à ¿À·ù¸¦ ÁÙÀÌ°í ÆíÀǼº°ú ¾ÈÀü¼ºÀ» ³ôÀÔ´Ï´Ù. »çÀü ÃæÀüµÈ ÁÖ»ç±â´Â ÷´Ü ¾ÈÀü ±â´ÉÀ» ÅëÇØ ¿À¿° À§Çè°ú ¹Ù´Ã¿¡ Âñ¸®´Â ¼Õ»óÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. »ç¿ë ÆíÀǼºÀÌ ¶Ù¾î³ª Ä¡·á ¿ä¹ý ¼øÀÀµµ¸¦ ³ôÀÌ°í, ƯÈ÷ ¸¸¼º Áúȯ ȯÀÚÀÇ ¼øÀÀµµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. Ä¡·á ¿ëµµ, ƯÈ÷ »ý¹°ÇÐÀû Á¦Á¦ ¹× ¸¸¼º Áúȯ Ä¡·á¿¡¼ ´ÙÀç´Ù´ÉÇÔÀº ÀÌ·¯ÇÑ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÇÔ²² ½ÃÀå¿¡¼ÀÇ ¿ìÀ§¸¦ ´õ¿í °ÈÇÕ´Ï´Ù.
Àç·áº°·Î´Â À¯¸® ÇÁ¸®ÇÊµå ½Ã¸°Áö ºÎ¹®ÀÌ ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀå¿¡¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯¸® ÁÖ»ç±â´Â ¿ì¼öÇÑ ÈÇÐÀû ºÒÈ°¼º Ư¼ºÀ¸·Î ¾à¹°ÀÇ ¾ÈÁ¤¼ºÀ» º¸ÀåÇÏ°í ¾à¹°°ú ¿ë±âÀÇ »óÈ£ ÀÛ¿ë À§ÇèÀ» °¨¼Ò½ÃÄÑ ´Ù¾çÇÑ Á¦¾à ÀÀ¿ë ºÐ¾ß¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ¶ÇÇÑ, À¯¸® ÁÖ»ç±â´Â °¡½Ã¼ºÀÌ ¶Ù¾î³ª ¾à¹°ÀÇ ¹Ì¸³ÀÚ³ª º¯»öÀ» ½±°Ô °Ë»çÇÒ ¼ö ÀÖ¾î Ç°Áú °ü¸®¿Í ȯÀÚ ¾ÈÀü¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ±× °á°ú, Á¦¾àȸ»ç¿Í ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â ¾à¹°Àü´ÞÀÇ ½Å·Ú¼º, ¾ÈÀü¼º ¹× È¿À²¼º ¶§¹®¿¡ À¯¸® ÇÁ¸®ÇÊµå ½Ã¸°Áö¸¦ ¼±È£ÇÏ°í ÀÖ½À´Ï´Ù.
µðÀÚÀκ°·Î º¸¸é ´ÜÀÏ Ã¨¹ö ÇÁ¸®Çʵå ÁÖ»ç±â ºÎ¹®Àº ¾à¹° Åõ¿©ÀÇ ÆíÀǼº, ¾ÈÀü¼º ¹× È¿À²¼º ¶§¹®¿¡ ÇÁ¸®Çʵå ÁÖ»ç±â ½ÃÀå¿¡¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ°í ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÔ´Ï´Ù. ¶ÇÇÑ, ÁÖ»ç °úÁ¤À» °£¼ÒÈÇÏ¿© ÀÇ·áÁø°ú ȯÀÚ°¡ ºü¸£°í ½±°Ô ÁÖ»çÇÒ ¼ö ÀÖ¾î ¼øÀÀµµ ¹× Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ´Ù¾çÇÑ Ä¡·á ºÐ¾ß, ƯÈ÷ ¸¸¼º Áúȯ °ü¸® ¹× ÀÀ±Þ ÀÇ·á ºÐ¾ß¿¡¼ ³Î¸® äÅõǰí ÀÖ´Ù´Â Á¡ÀÌ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â Àü ¼¼°è ÇÁ¸®ÇÊµå ½Ã¸°Áö ½ÃÀåÀ» Á¶»çÇÏ¿© À¯Çüº°, µðÀÚÀκ°, ¼ÒÀ纰, ¿ëµµº°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÀÔ ±â¾÷ °³¿ä µîÀ» Á¤¸®Çß½À´Ï´Ù.
The prefilled syringes market is projected to reach USD 13.1 billion by 2030 from USD 7.1 billion in 2024, at a CAGR of 10.8% during the forecast period. The prefilled syringes market has had strong growth due to a number of factors such as the rising incidences of chronic diseases like diabetes, rheumatoid arthritis, and cardiovascular disorders. Moreover, prefilled syringes make it easier to administer medications precisely and consistently to patients with chronic conditions, by providing ready-to-use doses that improve patient compliance and lower the possibility of dosage errors. Additionally, the growing trend of self-administration has also played a major role in the market's growth. Prefilled syringes are preferred by patients due to their comfort and ease of use, as they eliminate the need for dose measurement, hence improving safety and lowering the danger of contamination.
Scope of the Report | |
---|---|
Years Considered for the Study | 2022-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Units Considered | Value (USD Billion) |
Segments | By Type, Material, Design, Application, and Region |
Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the GCC countries |
"By type, conventional prefilled syringes segment is expected to have the largest market share in the prefilled syringes market."
Based on the type, the conventional prefilled syringes segment is expected to dominate the the prefilled syringes market due to several factors. Their ready-to-use nature and pre-measured doses enhance convenience and safety by reducing preparation time and dosing errors. They lower contamination risks and needle stick injuries through advanced safety features. Prefilled syringes improve patient compliance, particularly for chronic conditions, by being user-friendly and encouraging adherence to treatment regimens. Their versatility in therapeutic applications, especially for biologics and chronic disease treatments, coupled with the growing prevalence of such conditions, further drive their market dominance.
"By material, glass prefilled syringes segment is expected to have the largest market share in the prefilled syringes market."
Based on material, the glass prefilled syringe segment is expected to hold the largest market share in the prefilled syringes market. Their superior chemical inertness ensures drug stability and reduces the risk of interactions between the drug and the container, making them ideal for a wide range of pharmaceutical applications. Additionally, glass syringes offer high visibility, allowing for easy inspection of the drug for particulates and discoloration, which is critical for quality control and patient safety. As a result, pharmaceutical companies and healthcare providers prefer glass prefilled syringes for their reliability, safety, and efficiency in drug delivery.
"By design, single-chamber prefilled syringes segment is expected to have the largest market share in the prefilled syringes market."
Based on design, the single-chamber prefilled syringe segment accounted for the largest market share of the prefilled syringes market due to their convenience, safety, and efficiency in drug administration. These syringes, which come pre-loaded with a single dose of medication, minimize the risk of dosing errors and contamination, enhancing patient safety. They streamline the injection process, making it quicker and easier for healthcare providers and patients, thereby improving compliance and treatment outcomes. Moroever, their widespread adoption in various therapeutic areas, particularly in chronic disease management and emergency care, further drives growth in the market.
"By application, cancer segment is expected to have the largest market share in the prefilled syringes market."
By application, the cancer segment is expected to hold the largest market share due to the increasing prevalence of cancer globally and the rising need for advanced drug delivery systems. Prefilled syringes offer significant advantages for cancer treatment, including precise dosing, reduced risk of contamination, and enhanced patient safety and compliance. As cancer treatments often involve complex medication regimens requiring regular and accurate administration, the convenience and reliability of prefilled syringes become critical. Additionally, advancements in biologics and targeted therapies, which are frequently used in oncology, further drive the demand for prefilled syringes, making the cancer segment the dominant application area in this market.
"By region, North American region is expected to have the largest market share in the prefilled syringes market."
North America to register for the highest share of the prefilled syringes market during the forecast period due to several factors. These include a well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and a significant focus on patient safety and convenience. Moreover, the region benefits from robust regulatory frameworks that encourage the adoption of pre-filled syringes by ensuring stringent quality standards and safety measures. Additionally, increasing incidences of chronic diseases requiring regular injections, coupled with rising healthcare expenditures, contribute to the growing demand for pre-filled syringes in North America. The presence of major pharmaceutical companies and biotechnology firms further enhances market growth through extensive research and development activities aimed at improving drug delivery systems.
Prominent players in the prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), and West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Meidcal international Co., Ltd. (China), Credence MedSystems, Inc.(US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymedicure (India), MedXL (Canada), Sharps Technology, Inc.(US), Fresenius Kabi (US), DBM S.R.L. (Italy), Taisei Kako Co.,Ltd (Japan), Shandong Province Medicinal Glass Co., Ltd.(China), SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD (Japan), J.O. PHARMA CO., LTD. (Japan), BMIKOREA (Korea), B. Braun SE ( Germany), and Al Shifa Medical Products Co. (Saudi Arabia).
The report analyzes the prefilled syringes market and aims at estimating the market size and future growth potential of this market based on various segments such as type, material, design, application, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall prefilled syringes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.